FDA 483 - BLIS Technologies Limited - April 04, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
BLIS Technologies Limited, a dietary supplement manufacturer, received two observations during an FDA inspection in Dunedin, New Zealand. The firm failed to verify that finished batches of dietary supplements meet product specifications and lacked established acceptance criteria for strength specifications for certain ingredients. Additionally, the company did not provide the FDA with information on the scheduled process for a new acidified food product before packing it.
ID · 81b8d131-9e74-47f1-84af-1036629744bf